A Novel Approach for Development of Intraocular Biodegradable Ranibizumab Implant: A Solution for Stability of Protein Activity
Purpose: Ranibizumab is a monoclonal antibody fragment, targeting all isoforms of vascular endothelial growth factor A (VEGF-A), a protein involved in angiogenesis. It is used to treat age-related macular degeneration (AMD), retinal vein occlusion (RVO), and diabetic macular edema (DME), which are a...
Saved in:
Main Authors: | Fatemeh Dadgar Pakdel (Author), Ahmad Mirshahi (Author), Payam Zahedi (Author), Kazem Mohammad (Author), Farkhondeh Hemmati (Author), Javad Dadgar Pakdel (Author), Mohammad Hossein Nicknam (Author), Farid Abedin Dorkoosh (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polymeric Implants for the Treatment of Intraocular Eye Diseases: Trends in Biodegradable and Non-Biodegradable Materials
by: Paulina García-Estrada, et al.
Published: (2021) -
Effectiveness and safety of ranibizumab in a university hospital
by: Daniel Ribeiro, et al.
Published: (2024) -
Keratoacanthoma of the Nasal Septum Secondary to Ranibizumab Use
by: Jason E. Cohn, et al.
Published: (2017) -
Relationships between target intraocular pressure and central corneal thickness in stabilized and non-stabilized glaucoma patients
by: Dmitriev S. K., et al.
Published: (2021) -
ارزیابی قوس کف پا و میزان آسیب های غیر برخوردی زانو و مچ در کاراته کاهای مرد
by: Hossein Dadgar, et al.
Published: (2011)